MobileODT

What MobileODT does

MobileODT is a health-tech company founded in 2012 and headquartered in Tel Aviv, Israel, that develops portable medical devices for cervical cancer screening and pre-cancerous lesion detection. Its core product is a portable, easy-to-use cervical cancer screening device built on mobile optical detection technology, designed to bring point-of-care screening to settings where traditional colposcopy infrastructure is unavailable. The company targets the women's health / cervical cancer screening vertical, with a value proposition centered on accessibility, portability, and cost-effectiveness for underserved and resource-limited healthcare environments.

The company has raised approximately $14.1M across multiple funding rounds from 2012 through 2020, with OrbiMed as a repeat lead investor and participation from mission-aligned funds such as Laerdal Million Lives Fund, Tara Health Foundation, Tristel, MedTech Innovator, and Vodafone Americas Foundation. The company is led by CEO Leon A. Boston and operates with a small team of 11-50 employees. MobileODT has been acquired by Liger Medical, an altruistic organization focused on cost-effective women's healthcare devices, and now operates as a brand/subsidiary within Liger Medical's portfolio rather than as an independent entity.

MobileODT's business model historically centered on selling or distributing portable cervical cancer screening hardware and related consumables/services to healthcare providers, NGOs, and public health programs. Pricing details are not publicly disclosed. The product is positioned as a differentiated, miniaturized alternative to traditional colposcopy, with strategic alignment to global health cervical cancer screening initiatives.

Name

MobileODT

Website

http://www.mobileodt.com/

Company type

Private

Founded year

2012

Operating status

Acquired

Headcount range

11–50 employees

Short description

MobileODT develops portable, AI-based optical detection devices for cervical cancer screening, targeting healthcare providers and global health programs serving women in underserved settings. The company has been acquired by Liger Medical and operates as a brand within Liger Medical's women's healthcare device portfolio.

Ownership category

akta.pro rank

Product category

Cervical Cancer Screening Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)

akta.pro primary industry

Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

Keywords

• Cervical cancer screening
• Medical imaging devices
• Women's health technology
• Portable colposcopy
• AI medical diagnostics

Headquarters

HQ city

Tel Aviv

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Core offering

MobileODT develops and sells portable, AI-enabled medical devices for the screening and detection of pre-cervical cancer in women. The product line consists of compact optical imaging hardware combined with AI-based image analysis software, enabling healthcare providers to perform point-of-care cervical cancer screening in clinics, outreach programs, and underserved settings.

Differentiator

Problem solved

Functional benefit

Products and services

• Liger Medical Device Portfolio (MobileODT cervical cancer screening devices)

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Liger MedicalflagshipStrategic or Co-development Partner

Recent moves3 records

Expansion highlights3 records

Broad incumbents

• Hologic: Hologic is the dominant women's health diagnostics incumbent with ThinPrep cytology and Panther HPV testing platforms. It is the established standard-of-care cervical cancer screening vendor that any portable alternative must displace or complement.
• Becton, Dickinson and Company (BD): BD's Onclarity HPV assay and women's health diagnostics portfolio compete directly for cervical screening workloads. BD's scale, regulatory reach, and channel relationships make it a primary competitive benchmark.
• Roche Diagnostics: Roche's cobas HPV test is a flagship cervical cancer molecular diagnostic deployed globally. As a leading diagnostics platform, it defines the laboratory-based workflow that MobileODT's point-of-care device targets as an alternative or complement.
• CooperSurgical: CooperSurgical is a leading women's health medical device company spanning ART, obstetrics, and cervical screening/colposcopy products. It is a broad incumbent competing across the women's health device landscape MobileODT targets.
• Revvity (formerly PerkinElmer): Revvity provides clinical diagnostics and screening assays, including in oncology and women's health. As a broad diagnostics incumbent, it competes for the same cervical and women's health screening budgets as MobileODT.

Direct peers

• QIAGEN: QIAGEN provides digene HC2 and methylation-based cervical cancer screening assays (e.g., QIAsure). It directly competes in cervical diagnostics and is commonly co-evaluated alongside portable visual screening approaches.
• TruScreen: TruScreen is an emerging cervical cancer screening device using real-time opto-electrical tissue analysis at the point of care. It is one of the closest direct peers to MobileODT's portable visual AI screening offering.
• DYSIS Medical: DYSIS Medical builds DYSIS colposcopes with computer-aided mapping for cervical examination. It competes head-to-head in the portable colposcopy/visual screening segment that MobileODT addresses.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/MobileOCT
• Facebookfacebook.com/Mobileoct
• LinkedInlinkedin.com/company/mobileoct

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds6 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MobileODT